{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:40:58Z","timestamp":1780630858236,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.path.2023.05.010","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T09:42:36Z","timestamp":1687254156000},"page":"755-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mast Cell Disorders of the Gastrointestinal Tract"],"prefix":"10.1016","volume":"16","author":[{"given":"Nicole C.","family":"Panarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2023.05.010_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"61","article-title":"Mastocytosis","author":"Horny","year":"2017"},{"issue":"4","key":"10.1016\/j.path.2023.05.010_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2021.06.030","article-title":"Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee","volume":"148","author":"Zimmermann","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.path.2023.05.010_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2141.2008.07244.x","article-title":"Advances in the understanding of mast cell function","volume":"142","author":"Heib","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2023.05.010_bib4","first-page":"620","article-title":"A\u00a0Multi-Functional Master Cell","volume":"6","author":"Krystel-Whittemore","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.path.2023.05.010_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/gutjnl-2015-309151","article-title":"The role of mast cells in functional GI disorders","volume":"65","author":"Wouters","year":"2016","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.path.2023.05.010_bib6","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1097\/MIB.0000000000000142","article-title":"The multifaceted mast cell in inflammatory bowel disease","volume":"20","author":"Hamilton","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.path.2023.05.010_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000487538","article-title":"The Staining of Mast Cells: A Historical Overview","volume":"176","author":"Ribatti","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.iac.2014.01.005","article-title":"Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells","volume":"34","author":"Horny","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"12","key":"10.1016\/j.path.2023.05.010_bib9","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1080\/1042819021000039965","article-title":"Tryptase a novel biochemical marker of acute myeloid leukemia","volume":"43","author":"Sperr","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.path.2023.05.010_bib10","first-page":"e9577","article-title":"Tryptase Positivity in Chronic Myeloid Leukemia With Marked Basophilia","volume":"12","author":"Khafateh","year":"2020","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.path.2023.05.010_bib11","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1007\/s13277-014-1899-8","article-title":"Diagnostic value of CD117 in differential diagnosis of acute leukemias","volume":"35","author":"Ahmadi","year":"2014","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00281-009-0165-4","article-title":"Physiological and pathophysiological functions of intestinal mast cells","volume":"31","author":"Bischoff","year":"2009","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1309\/AJCPSGQ71GJQQACL","article-title":"Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis","volume":"144","author":"Reichard","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(05)70298-7","article-title":"Gastrointestinal abnormalities and involvement in systemic mastocytosis","volume":"14","author":"Jensen","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.path.2023.05.010_bib15","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/PAS.0b013e318078ce7a","article-title":"Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis","volume":"31","author":"Hahn","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.05.010_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/his.13033","article-title":"Clinicopathological characteristics of systemic mastocytosis in the intestine","volume":"69","author":"Shih","year":"2016","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.path.2023.05.010_bib17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","article-title":"A\u00a0clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients","volume":"38","author":"Doyle","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2023.05.010_bib18","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000001126","article-title":"Are Enterocolic Mucosal Mast Cell Aggregates Clinically Relevant in Patients Without Suspected or Established Systemic Mastocytosis?","volume":"42","author":"Johncilla","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2023.05.010_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG Clinical Guideline: Management of Irritable Bowel Syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroentero"},{"key":"10.1016\/j.path.2023.05.010_bib20","article-title":"Bowel Disorders","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.path.2023.05.010_bib21","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","article-title":"Activation of the mucosal immune system in irritable bowel syndrome","volume":"122","author":"Chadwick","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2036.2007.03370.x","article-title":"Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain","volume":"26","author":"Nyrop","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.path.2023.05.010_bib23","first-page":"250","article-title":"The Emerging Role of Mast Cells in Irritable Bowel Syndrome","volume":"14","author":"Boeckxstaens","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"9","key":"10.1016\/j.path.2023.05.010_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/gutjnl-2013-306236","article-title":"Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations","volume":"64","author":"Vicario","year":"2015","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.path.2023.05.010_bib26","doi-asserted-by":"crossref","first-page":"e13718","DOI":"10.1111\/nmo.13718","article-title":"Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis","volume":"31","author":"Robles","year":"2019","journal-title":"Neuro Gastroenterol Motil"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/nmo.12250","article-title":"Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS","volume":"26","author":"Di Nardo","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"1 Pt 1","key":"10.1016\/j.path.2023.05.010_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","article-title":"Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome","volume":"21","author":"Park","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"45","key":"10.1016\/j.path.2023.05.010_bib29","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.3748\/wjg.v13.45.i6041","article-title":"Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome","volume":"13","author":"Wang","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.path.2023.05.010_bib30","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/gut.2003.021154","article-title":"Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis","volume":"53","author":"Wang","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.path.2023.05.010_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13192","article-title":"Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis","volume":"30","author":"Bashashati","year":"2018","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.path.2023.05.010_bib32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10620-013-2930-4","article-title":"Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis","volume":"59","author":"Ahn","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.path.2023.05.010_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365521.2013.857712","article-title":"Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea","volume":"49","author":"Sohn","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI29255","article-title":"Role for protease activity in visceral pain in irritable bowel syndrome","volume":"117","author":"Cenac","year":"2007","journal-title":"J\u00a0Clin Investr"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5056\/jnm.2013.19.2.244","article-title":"Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome","volume":"19","author":"Lee","year":"2013","journal-title":"J\u00a0Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ajg.2011.423","article-title":"Serum and colonic mucosal immune markers in irritable bowel syndrome","volume":"107","author":"Chang","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.path.2023.05.010_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/mmr.2013.1320","article-title":"Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome","volume":"7","author":"El-Salhy","year":"2013","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.path.2023.05.010_bib38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/2050640617691690","article-title":"Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study","volume":"5","author":"Lobo","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"9","key":"10.1016\/j.path.2023.05.010_bib39","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2010.213108","article-title":"The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome","volume":"59","author":"Klooker","year":"2010","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2036.2009.04041.x","article-title":"Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study","volume":"30","author":"Corinaldesi","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.path.2023.05.010_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gutjnl-2014-308188","article-title":"Randomised controlled trial of mesalazine in IBS","volume":"65","author":"Barbara","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5858\/2006-130-362-MEIMMC","article-title":"Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea","volume":"130","author":"Jakate","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2023.05.010_bib43","doi-asserted-by":"crossref","first-page":"950582","DOI":"10.1155\/2012\/950582","article-title":"Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility","volume":"2012","author":"Akhavein","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.path.2023.05.010_bib45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.path.2023.05.010_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations","volume":"128","author":"Hamilton","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.path.2023.05.010_bib47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.path.2023.05.010_bib48","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clinthera.2013.04.001","article-title":"Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes","volume":"35","author":"Picard","year":"2013","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib49","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.path.2023.05.010_bib51","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14309\/ajg.0000000000000474","article-title":"Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis","volume":"115","author":"Bolton","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.path.2023.05.010_bib53","doi-asserted-by":"crossref","first-page":"685865","DOI":"10.3389\/fimmu.2021.685865","article-title":"Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles","volume":"12","author":"Jimenez","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.path.2023.05.010_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coph.2015.11.005","article-title":"Mast cells and inflammatory bowel disease","volume":"25","author":"Boeckxstaens","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.path.2023.05.010_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-800267-4.00006-7","article-title":"Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing","volume":"122","author":"Douaiher","year":"2014","journal-title":"Adv Immunol"},{"issue":"2","key":"10.1016\/j.path.2023.05.010_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/gut.45.2.210","article-title":"Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin","volume":"45","author":"Gelbmann","year":"1999","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.path.2023.05.010_bib57","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gutjnl-2012-304066","article-title":"Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation","volume":"63","author":"Vivinus-Nebot","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.path.2023.05.010_bib58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MCG.0000000000001394","article-title":"Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission","volume":"55","author":"Fan","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:09Z","timestamp":1761748989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1875918123000508"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.05.010","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast Cell Disorders of the Gastrointestinal Tract","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}